
Ekso Bionics Holdings EKSO
Quartalsbericht 2026-Q1
hinzugefügt 28.04.2026
Ekso Bionics Holdings Kurzfristige Verbindlichkeiten 2011-2026 | EKSO
Kurzfristige Verbindlichkeiten Jährlich Ekso Bionics Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.64 M | 7.54 M | 8.12 M | 9.2 M | 6.86 M | 4.97 M | 7.83 M | 10.1 M | 9.16 M | 6.31 M | 8.62 M | 6.61 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 10.1 M | 4.97 M | 7.83 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Medizinische Instrumente
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
12.6 K | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
1.11 B | $ 62.02 | 2.78 % | $ 12.3 B | ||
|
Luminex Corporation
LMNX
|
87.5 M | - | - | $ 1.75 B | ||
|
Glaukos Corporation
GKOS
|
101 M | $ 121.69 | 7.08 % | $ 6.96 B | ||
|
Akers Biosciences, Inc.
AKER
|
1.53 M | - | -9.52 % | $ 20.6 M | ||
|
Intuitive Surgical
ISRG
|
2.01 B | $ 418.82 | 2.83 % | $ 149 B | ||
|
ICU Medical
ICUI
|
499 M | $ 134.93 | 3.38 % | $ 3.32 B | ||
|
iRhythm Technologies
IRTC
|
152 M | $ 107.35 | 2.67 % | $ 3.44 B | ||
|
Repro Med Systems
KRMD
|
8.19 M | $ 4.14 | 5.61 % | $ 191 M | ||
|
Antares Pharma, Inc.
ATRS
|
63.2 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
179 M | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
11.8 M | - | - | $ 282 M | ||
|
LeMaitre Vascular
LMAT
|
36.3 M | $ 93.56 | 2.1 % | $ 2.12 B | ||
|
Hill-Rom Holdings, Inc.
HRC
|
952 M | - | -0.05 % | $ 10.3 B | ||
|
Masimo Corporation
MASI
|
618 M | $ 178.9 | 0.07 % | $ 9.54 B | ||
|
Microbot Medical
MBOT
|
3.42 M | $ 1.96 | -0.51 % | $ 89.7 M | ||
|
Milestone Scientific
MLSS
|
4.13 M | $ 0.43 | 11.28 % | $ 35.3 M | ||
|
Varian Medical Systems, Inc.
VAR
|
1.85 B | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
11.3 M | $ 9.94 | 0.81 % | $ 84.3 K | ||
|
Envista Holdings Corporation
NVST
|
853 M | $ 22.87 | 2.1 % | $ 3.84 B | ||
|
Haemonetics Corporation
HAE
|
283 M | $ 69.85 | 6.03 % | $ 3.3 B | ||
|
Isoray
ISR
|
28.7 M | - | 0.03 % | $ 108 M | ||
|
STERIS plc
STE
|
1.14 B | $ 212.24 | 0.98 % | $ 20.8 B | ||
|
STAAR Surgical Company
STAA
|
68.5 M | $ 29.86 | 5.66 % | $ 1.48 B | ||
|
InfuSystem Holdings
INFU
|
20.2 M | $ 9.12 | 1.0 % | $ 188 M | ||
|
Teleflex Incorporated
TFX
|
762 M | $ 132.11 | 2.76 % | $ 5.9 B | ||
|
Merit Medical Systems
MMSI
|
240 M | $ 63.04 | 3.94 % | $ 3.73 B | ||
|
Utah Medical Products
UTMD
|
2.6 M | $ 67.99 | 3.75 % | $ 220 M | ||
|
West Pharmaceutical Services
WST
|
655 M | $ 317.32 | 0.32 % | $ 22.9 B | ||
|
DENTSPLY SIRONA
XRAY
|
1.34 B | $ 9.88 | 2.49 % | $ 1.97 B | ||
|
Pulse Biosciences
PLSE
|
7.92 M | $ 26.94 | 7.8 % | $ 1.82 B | ||
|
Retractable Technologies
RVP
|
9.6 M | $ 0.66 | 0.41 % | $ 19.8 M | ||
|
Pro-Dex
PDEX
|
14.6 M | $ 67.0 | 2.81 % | $ 220 M | ||
|
Predictive Oncology
POAI
|
4.27 M | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
23 M | $ 27.09 | -0.59 % | $ 1.29 B | ||
|
Stereotaxis
STXS
|
22.4 M | $ 1.88 | 2.17 % | $ 171 M | ||
|
Baxter International
BAX
|
2.97 B | $ 19.35 | 4.37 % | $ 9.93 B | ||
|
ResMed
RMD
|
689 M | $ 194.32 | 4.22 % | $ 28.4 B | ||
|
AtriCure
ATRC
|
81.5 M | $ 27.27 | 4.08 % | $ 1.3 B | ||
|
Harvard Bioscience
HBIO
|
22 M | $ 6.48 | -0.31 % | $ 288 M | ||
|
NeuroMetrix
NURO
|
1.01 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
76.2 M | $ 12.03 | 7.41 % | $ 491 M | ||
|
Becton, Dickinson and Company
BDX
|
8.31 B | $ 149.56 | 2.73 % | $ 43 B | ||
|
Nephros
NEPH
|
2.77 M | $ 3.59 | -1.37 % | $ 38.1 M | ||
|
OraSure Technologies
OSUR
|
39.8 M | $ 4.17 | 5.57 % | $ 306 M | ||
|
Repligen Corporation
RGEN
|
136 M | $ 126.55 | 3.96 % | $ 7.12 M |